Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Brazil

Brazil

In Brazil, the revenue generated in the Digestives & Intestinal Remedies market market is estimated to reach €0.83bn in 2024.
It is projected to experience an annual growth rate of 4.00% (CAGR 2024-2029).
When compared globally, in China leads the market with revenue of €4,087.00m in 2024.
Taking into account the total population, per person revenues are approximately €3.81 in 2024.
Brazil's growing interest in natural and herbal remedies has led to an increased demand for digestive and intestinal remedies in the OTC Pharmaceuticals market.

Key regions: Canada, United States, Australia, Brazil, Japan

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Digestives & Intestinal Remedies market in Brazil is experiencing significant growth and development.

Customer preferences: Customers in Brazil are increasingly seeking out Digestives & Intestinal Remedies to address a variety of digestive issues. This is driven by a growing awareness of the importance of digestive health and an increasing focus on preventative healthcare. Consumers are looking for products that are effective, convenient, and affordable. They are also interested in natural and herbal remedies, as well as products that are free from artificial ingredients and preservatives.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Brazil is the rising demand for probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help to restore the natural balance of bacteria in the gut and can alleviate symptoms of digestive disorders such as bloating, constipation, and diarrhea. Probiotics are available in a variety of forms, including supplements, yogurts, and fermented foods. The increasing popularity of probiotics is driven by the growing understanding of the importance of gut health and the role of the microbiome in overall well-being.Another trend in the market is the growing popularity of natural and herbal remedies. Consumers in Brazil are increasingly seeking out products that are derived from natural sources and are free from artificial ingredients and preservatives. This is driven by a desire for more holistic and sustainable approaches to healthcare. Natural and herbal remedies for digestive issues include ingredients such as ginger, peppermint, chamomile, and aloe vera. These ingredients have been used for centuries to soothe and support digestion.

Local special circumstances: Brazil has a rich tradition of herbal medicine and natural remedies. The country is home to a wide variety of plants and herbs with medicinal properties. This has led to a strong demand for natural and herbal remedies in the Digestives & Intestinal Remedies market. Local companies are capitalizing on this demand by developing innovative products that incorporate traditional Brazilian ingredients. This gives them a competitive advantage in the market and appeals to consumers who are looking for locally sourced and culturally relevant products.

Underlying macroeconomic factors: The growth of the Digestives & Intestinal Remedies market in Brazil is also influenced by underlying macroeconomic factors. Brazil has a large and growing middle class with increasing disposable income. This has led to a greater focus on health and wellness and an increased willingness to spend on healthcare products. The country also has a rapidly aging population, which is driving demand for products that address age-related digestive issues. Additionally, the Brazilian government has implemented policies to promote the use of natural and herbal remedies, which has further fueled the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.